WuXi Biologics (Cayman) (WXXWY) News Today $5.67 -0.09 (-1.52%) As of 03/3/2025 03:56 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period WuXi Biologics Launches EffiX™ Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA ProductionMarch 3 at 7:30 PM | prnewswire.comShort Interest in WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Declines By 53.6%March 3 at 1:46 AM | americanbankingnews.comWuXi Biologics Again Passed GMP Inspection by Japan PMDAFebruary 26, 2025 | prnewswire.comWuXi Biologics Awarded Platinum Medal by EcoVadis Sustainability Rating for Second Consecutive YearFebruary 18, 2025 | prnewswire.comWuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive YearFebruary 10, 2025 | prnewswire.comWuXi Biologics: Buy Rating Supported by Strong Performance, Strategic Growth, and Increased Target PriceJanuary 18, 2025 | markets.businessinsider.comWuxi Biologics upgraded to Overweight from Neutral at JPMorganJanuary 7, 2025 | markets.businessinsider.comWuXi Bio to Sell Vaccine Facility to Merck for $500 MillionJanuary 7, 2025 | bloomberg.comCandid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-cell EngagerJanuary 6, 2025 | businesswire.comWuXi Biologics Announces Agreement with Candid Therapeutics on Trispecific T-cell EngagerJanuary 6, 2025 | prnewswire.comChina's WuXi Biologics to sell Ireland vaccine facility to Merck for $500 millionJanuary 6, 2025 | reuters.comWuXi Biologics Ranks Top in 2024 Dow Jones Sustainability Indices for Second Consecutive YearJanuary 2, 2025 | prnewswire.comWuXi Biologics Included in UNGC 20 Case Examples of Sustainable Development for 20 Years CollectionDecember 12, 2024 | prnewswire.comWuXi Biologics Achieves Major Milestones at Ireland Site with Multiple 16,000L PPQ Success and HPRA GMP AuthorizationsDecember 5, 2024 | prnewswire.comWuXi Biologics Updates Board and CommitteesNovember 21, 2024 | markets.businessinsider.comWuXi Biologics Germany to Enhance Capabilities with New Prefilled Syringes LineNovember 13, 2024 | prnewswire.comWuXi Biologics Launches WuXia™ RidGS for Non-Antibiotic Cell Line DevelopmentOctober 28, 2024 | prnewswire.comWuxi Biologics (Cayman) (WXIBF) Receives a Buy from JefferiesOctober 27, 2024 | markets.businessinsider.comDBS Keeps Their Hold Rating on Wuxi Biologics (Cayman) (WXIBF)October 16, 2024 | markets.businessinsider.comWuXi Biologics Receives ESG Corporate Platinum Award from The Asset for Fourth Consecutive YearOctober 16, 2024 | prnewswire.comDBS Remains a Hold on Wuxi Biologics (Cayman) (WXIBF)October 10, 2024 | markets.businessinsider.comWuXi Biologics (Cayman) Inc (WXXWY) Half Year 2024 Earnings Call Highlights: Navigating Growth ...October 10, 2024 | finance.yahoo.comWuxi Biologics (Cayman) (WXIBF) Gets a Buy from DBSSeptember 27, 2024 | markets.businessinsider.comWuXi Biologics Included in Hang Seng ESG 50 IndexSeptember 23, 2024 | prnewswire.comWuXi Biologics Successfully Completes First Scale-Up of High-Productivity Bioprocessing Platform WuXiUI™ in 2,000L GMP ManufacturingAugust 30, 2024 | prnewswire.comWuXi Biologics: A Strong Buy Amidst Global Demand and Robust Growth DriversAugust 27, 2024 | markets.businessinsider.comWuXi Biologics (Cayman) Inc. (WXXWY) Q2 2024 Earnings Call TranscriptAugust 22, 2024 | seekingalpha.comWuXi Biologics Reports Solid 2024 Interim ResultsAugust 21, 2024 | prnewswire.comWuXi Biologics and Medigene Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell EngagersAugust 8, 2024 | prnewswire.comMedigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell EngagersAugust 8, 2024 | globenewswire.comWuXi Biologics' Four Manufacturing Facilities and Biosafety Testing Center Certified Again by European Medicines Agency for Ten BiologicsAugust 1, 2024 | prnewswire.comWuXi Biologics (Cayman) IncJuly 23, 2024 | morningstar.comWuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth YearJuly 10, 2024 | prnewswire.comWuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability CommitmentApril 29, 2024 | prnewswire.comWuXi Biologics: Staying On The SidelinesApril 26, 2024 | seekingalpha.comAstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'April 25, 2024 | finance.yahoo.comWuXi Biologics (Cayman) Inc (1FW1.SG)April 16, 2024 | finance.yahoo.comWuxi Biologics: A Strong Buy Based on Robust Sales Growth, Strategic Expansion, and Financial StabilityApril 2, 2024 | markets.businessinsider.comWuXi Biologics Reports Solid 2023 Annual ResultsMarch 26, 2024 | prnewswire.comWuXi Biologics Named to CDP 'A List' for Water SecurityMarch 22, 2024 | prnewswire.comHong Kong Stocks: WuXi Biologics Shares Tumble on US Biotech Bill ConcernsMarch 8, 2024 | msn.comWuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change AssessmentMarch 5, 2024 | finance.yahoo.comWuXi Biologics Recognized as Both Industry and Regional ESG Top-Rated Company by Morningstar SustainalyticsFebruary 21, 2024 | prnewswire.comWuxi Biologics: Navigating the Biosecure Act with Resilience and OptimismFebruary 14, 2024 | markets.businessinsider.comWuXi Biologics Successfully Completes First 1,6000L Manufacturing Run in IrelandJanuary 31, 2024 | finance.yahoo.comWuxi Biologics (Cayman) Buy Rating: Growth Potential and Strong Compliance StandardsJanuary 30, 2024 | markets.businessinsider.comWuXi Bio Denies Military Ties After Shares Slumped on US BillJanuary 28, 2024 | bloomberg.comWuXi AppTec, Wuxi Bio Tumble as US Lawmakers Propose BanJanuary 26, 2024 | finance.yahoo.comUS lawmaker moves bill to ban Chinese biotech firms from federal contracts, alleging complicity with militaryJanuary 26, 2024 | finance.yahoo.comChinese Biotech Stocks Plunge on Proposed U.S. LegislationJanuary 26, 2024 | finance.yahoo.com Get WuXi Biologics (Cayman) News Delivered to You Automatically Sign up to receive the latest news and ratings for WXXWY and its competitors with MarketBeat's FREE daily newsletter. Email Address WXXWY Media Mentions By Week WXXWY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WXXWY News Sentiment▼0.660.70▲Average Medical News Sentiment WXXWY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WXXWY Articles This Week▼40▲WXXWY Articles Average Week Get WuXi Biologics (Cayman) News Delivered to You Automatically Sign up to receive the latest news and ratings for WXXWY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News AKBLF News DRTSW News APLMW News ARNI News ASPHF News ASCLF News AVCTF News AWKNF News BRRGF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:WXXWY) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WuXi Biologics (Cayman) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share WuXi Biologics (Cayman) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
